Booth No. : A31
Presentation Representative : Masaru Tomita
Person in Charge of the Project : Megumi Uetaki
Intravenous administration of high-dose vitamin C has recently been attracting attentions as a cancer therapy. Recent studies suggested that high-dose vitamin C selectively kills cancer cells, so this therapy has fewer side effects than anticancer drug. However, the cytotoxic mechanism of vitamin C in cancer cells has not been clarified yet. Here, we focused on the metabolic changes of cancer cells treated with high-dose vitamin C by metabolome analysis. The results of this study suggest that high-dose vitamin C impedes energy metabolism of cancer cells.
